Skip to content

What are the most common side effects of pioglitazone?

5 min read

In 2023, pioglitazone was the 133rd most prescribed medication in the United States, with over 4 million prescriptions [1.3.4]. This article answers the question: What are the most common side effects of pioglitazone?, while also exploring serious risks and management strategies.

Quick Summary

Pioglitazone, a medication for type 2 diabetes, commonly causes side effects like upper respiratory infections, headaches, weight gain, and swelling [1.2.2]. More serious risks include heart failure, bone fractures, and potential bladder cancer risk [1.4.4, 1.2.2].

Key Points

  • Common Side Effects: The most common side effects include upper respiratory tract infections, headache, muscle pain, weight gain, and swelling (edema) [1.2.2].

  • Heart Failure Risk: Pioglitazone has a boxed warning for causing or worsening congestive heart failure due to fluid retention [1.2.2, 1.4.4].

  • Bone Fracture Risk: The medication is associated with an increased risk of bone fractures, especially in the hands, arms, or feet of female patients [1.2.2, 1.5.3].

  • Bladder Cancer Concern: Long-term use (over a year) may be linked to an increased risk of bladder cancer; it is contraindicated in patients with active bladder cancer [1.4.2].

  • Mechanism of Action: Pioglitazone is a thiazolidinedione (TZD) that works by making body cells more sensitive to insulin [1.3.4].

  • Weight Gain: Unlike some other diabetes drugs, pioglitazone commonly causes weight gain, which can be from both fluid retention and fat redistribution [1.7.2, 1.5.6].

  • Drug Interactions: Pioglitazone can interact with various drugs, including insulin (increasing heart failure risk) and some oral contraceptives (reducing their effectiveness) [1.8.1, 1.4.4].

In This Article

Understanding Pioglitazone (Actos)

Pioglitazone, sold under the brand name Actos among others, is an oral anti-diabetic medication used to improve blood sugar control in adults with type 2 diabetes [1.3.4, 1.4.5]. It is not used for treating type 1 diabetes or diabetic ketoacidosis [1.4.2, 1.4.5]. Pioglitazone is part of a class of drugs called thiazolidinediones (TZDs) and works by increasing the body's sensitivity to insulin, the hormone that regulates blood sugar [1.3.3, 1.3.4]. By enhancing how insulin works in muscle, fat, and liver cells, it helps lower blood glucose levels [1.3.1]. This medication is typically used in conjunction with a healthy diet and regular exercise [1.3.4].

How Pioglitazone Works

Pioglitazone's mechanism of action involves activating specific nuclear receptors known as peroxisome proliferator-activated receptor gamma (PPAR-γ) [1.3.4]. This activation changes the expression of genes involved in glucose and lipid metabolism [1.3.5]. The result is increased glucose uptake in the body's peripheral tissues and reduced glucose production in the liver, which collectively helps to lower blood sugar and reduce insulin resistance [1.3.5]. Because it relies on changing gene expression, its maximum therapeutic effect can take weeks or even months to be fully realized [1.3.3].

Common Side Effects of Pioglitazone

While effective for many, pioglitazone is associated with several common side effects. Many of these are mild and may lessen as your body adjusts to the medication [1.2.2].

  • Upper Respiratory Tract Infections: Infections such as the common cold and sinus infections are among the most frequently reported side effects [1.2.2, 1.4.4].
  • Headache: Headaches are a possible side effect, though they can also be a symptom of high or low blood sugar, so monitoring glucose levels is important [1.2.2, 1.2.4].
  • Weight Gain: Patients taking pioglitazone may experience weight gain, which can be a result of both increased subcutaneous fat and fluid retention [1.3.4, 1.7.2]. On average, patients may gain about 2 kg (4.4 lbs) [1.7.2].
  • Swelling (Edema): Fluid retention is a known side effect that can cause swelling in the feet, ankles, hands, or lower legs [1.2.2, 1.2.4]. This effect is dose-related and can be more pronounced when pioglitazone is taken with insulin [1.7.2, 1.5.1].
  • Muscle Pain (Myalgia): Muscle aches are another potential side effect reported by some patients [1.2.2, 1.2.6].
  • Sore Throat (Pharyngitis): Inflammation or soreness of the throat can also occur [1.2.2, 1.4.2].

Serious Side Effects and Risks

Beyond the common side effects, pioglitazone carries warnings for several serious health risks that require immediate medical attention.

Heart Failure

Pioglitazone has a boxed warning from the FDA, the strictest warning, for causing or worsening congestive heart failure [1.2.2, 1.4.4]. The drug can cause the body to retain extra fluid, which increases the workload on the heart [1.2.2]. Symptoms include rapid weight gain, shortness of breath (especially when lying down), swelling, and unusual tiredness [1.2.6]. It is contraindicated in patients with established New York Heart Association (NYHA) Class III or IV heart failure [1.4.2].

Bone Fractures

Long-term use of pioglitazone has been linked to an increased risk of bone fractures, particularly in women [1.2.2, 1.5.3]. A clinical study showed that women taking pioglitazone had nearly double the rate of bone fractures compared to those who did not, with the majority occurring in the hands, upper arms, or feet [1.4.4, 1.5.3]. This may be related to decreased bone mineral density [1.2.2].

Bladder Cancer

There is a potential increased risk of bladder cancer with pioglitazone use, especially with long-term use (more than one year) [1.4.2, 1.9.1]. While some studies show a link, others have found no statistically significant association [1.5.1, 1.5.6]. Due to this risk, pioglitazone should not be used in patients with active bladder cancer and should be used with caution in those with a history of it [1.4.2]. Symptoms to watch for include blood in the urine, painful urination, or a new or worsening urge to urinate [1.4.5].

Liver Problems

Although rare, pioglitazone can cause liver damage [1.2.6]. Patients should immediately contact their doctor if they experience symptoms like nausea, vomiting, upper stomach pain, dark urine, or yellowing of the skin or eyes (jaundice) [1.4.5].

Macular Edema

Some individuals taking pioglitazone have developed macular edema, which is swelling in the back of the eye that can affect vision [1.2.2]. The risk may be higher for those also taking insulin [1.2.2]. Any changes in vision should be reported to a healthcare provider [1.2.3].

Comparison Table: Pioglitazone vs. Metformin

Metformin is often the first-line medication for type 2 diabetes. The table below compares it with pioglitazone.

Feature Pioglitazone (Actos) Metformin
Mechanism Increases insulin sensitivity in peripheral tissues and the liver (PPAR-γ agonist) [1.3.1, 1.3.4]. Reduces glucose production by the liver and absorption from the stomach; improves insulin sensitivity [1.6.3].
Common Side Effects Upper respiratory infection, headache, weight gain, swelling (edema) [1.2.2]. Diarrhea, nausea, gas, upset stomach [1.2.5].
Weight Effect Weight gain is common [1.7.2]. Generally weight-neutral or may cause slight weight loss [1.6.2].
Heart Failure Risk Boxed warning for causing or worsening heart failure [1.2.2, 1.4.4]. Lower risk; may have some cardiovascular benefits. Lactic acidosis is a rare but serious risk [1.2.5].
Hypoglycemia Risk Low risk when used alone; risk increases when combined with insulin or sulfonylureas [1.2.2]. Low risk when used alone [1.2.5].

Managing Side Effects and Important Considerations

Before starting pioglitazone, it's crucial to inform your doctor about your full medical history, especially if you have heart failure, liver disease, bladder cancer, or osteoporosis [1.4.1, 1.4.4].

To manage side effects:

  • Weight Gain & Swelling: Adhering to a healthy diet and exercise plan can help manage weight [1.7.1]. If you notice sudden weight gain or swelling, contact your doctor, as this could be a sign of heart failure [1.2.6]. They may suggest elevating your legs or using compression socks [1.7.2].
  • Bone Health: Discuss ways to keep your bones strong with your doctor, such as adequate calcium intake and weight-bearing exercise [1.7.2].
  • Hypoglycemia: When pioglitazone is taken with other diabetes drugs like insulin, the risk of low blood sugar increases [1.2.2]. Know the symptoms (shakiness, dizziness, sweating, confusion) and always have a source of fast-acting sugar available [1.2.3, 1.7.4].
  • Drug Interactions: Pioglitazone can interact with other medications. For example, it can reduce the effectiveness of hormonal birth control [1.4.4]. Topiramate may decrease pioglitazone levels, while gemfibrozil can increase them, raising the risk of side effects [1.8.1, 1.8.5]. Always inform your healthcare provider of all medications you are taking [1.7.4].

Conclusion

Pioglitazone is an effective medication for managing type 2 diabetes by improving the body's use of insulin. However, it is essential to be aware of what the most common side effects of pioglitazone are, such as upper respiratory infections, weight gain, and edema [1.2.2]. More importantly, patients and healthcare providers must be vigilant about serious risks, including the potential to cause or worsen heart failure, an increased risk of bone fractures in women, and a possible link to bladder cancer [1.4.4]. A thorough discussion of the benefits and risks with a healthcare provider is necessary to determine if pioglitazone is the right choice for an individual's diabetes management plan.

For more detailed information, you can consult the FDA's Medication Guide for Pioglitazone.

Frequently Asked Questions

The most serious side effect is its potential to cause or worsen congestive heart failure. The FDA has issued a boxed warning for this risk [1.2.2, 1.4.4].

Yes, weight gain is a common side effect of pioglitazone. This can be due to both fluid retention (edema) and an increase in subcutaneous fat [1.3.4, 1.7.2].

Pioglitazone is not recommended for patients with symptomatic heart failure and is contraindicated for those with severe (NYHA Class III or IV) heart failure due to the risk of fluid retention worsening the condition [1.4.2, 1.4.4].

It may take 2 weeks for your blood sugar to begin decreasing, but the full effect of pioglitazone may not be felt for 2 to 3 months [1.9.5].

When taken on its own, pioglitazone has a low risk of causing low blood sugar. However, the risk increases significantly when it is taken in combination with other diabetes medications like insulin or sulfonylureas [1.2.2].

Some studies suggest that using pioglitazone for more than one year may be linked to an increased risk of bladder cancer. Therefore, it is not prescribed for patients with active bladder cancer [1.4.2, 1.9.1].

Pioglitazone has been linked to an increased risk of bone fractures in women, particularly in the hands, upper arms, or feet [1.4.4]. This may be due to the drug causing decreased bone mineral density [1.2.2].

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.